As we communicated previously, Harvard Pilgrim Health Care and Tufts Health Plan are reviewing our existing payment policies as part of our integration work as a combined organization, assessing opportunities for consistency in addition to our typical annual review.
As a result of this ongoing review, Harvard Pilgrim’s commercial Human Leukocyte Antigen Testing and Blood Products and Services Payment Policies have been archived, effective Sept. 1, 2021. While we will no longer be maintaining those policy documents, the reimbursement information and requirements listed on them still apply and can now be found on the Laboratory and Pathology Payment Policy.
In addition, the Inpatient Transfer Between Hospitals Payment Policy will be archived on Oct. 1, 2021, and any pertinent information from that policy will be moved to the Inpatient Acute Medical Admissions Payment Policy.
To view our Payment Policies, please refer to the Provider Manual on our provider website.